Patients randomized to monotherapy were titrated from losartan 50 mg to losartan 100 mg to losartan 150 mg. (This latter dosage is not currently approved by the United States Food and Drug ...

In this study, the authors compared the effects of high-dose (150 mg) versus low-dose (50 mg) losartan on clinical outcomes in patients with heart failure. This randomised trial was done in 255 ...

This covers lot No. JB8912 of Losartan Potassium Hydrochlorothiazide 100 mg or 25 mg tablets in 1,000-count bottles, expiration date 06/2020. None of the recalled tablets were distributed before ...

Andersson and Neldam [5] evaluated candesartan cilexetil 8 and 16 mg vs. losartan 50 mg and found that candesartan cilexetil 16 mg once daily (n=84) reduced trough DBP more effectively than ...

The affected Losartan Potassium tablets being recalled are described as: Losartan Potassium tablets, USP 25 mg, are light-green, film-coated, teardrop-shaped biconvex tablet with “LK 25” on ...

A total of 1513 patients were enrolled in this randomized, double-blind study comparing losartan (50 to 100 mg once daily ... mm Hg in the losartan group and 150/80 mm Hg in the placebo group ...

This study compared the antihypertensive efficacy of a triple-combination, fixed-dose therapy of losartan 50 mg (L50)/hydrochlorothiazide 12.5 mg (H12.5)/amlodipine 5 mg (A5) versus co ...